The Medtronic Newsroom is designed to assist media in finding news and information about our company.
Medtronic, founded in a Minneapolis garage in 1949 by Earl Bakken and his brother-in-law, Palmer Hermundslie, is the world’s leading maker of medical devices.
Our Mission has not changed since Earl Bakken wrote it in 1960: To contribute to human welfare by application of biomedical engineering in the research, design, manufacture, and sale of instruments or appliances that alleviate pain, restore health and extend life.
More than 9 million lives are enhanced every year by a Medtronic product or therapy; that’s one every three seconds.
Medtronic is headquartered in Minneapolis, MN and operates in more than 140 countries. The company employs 46,000 people, including 5,800 scientists and engineers, pursuing research and innovation that has led to more than 28,000 patents.
|03/06/14||Medtronic CFO Gary Ellis to Speak at Barclays Global Healthcare Conference|
|MINNEAPOLIS - Mar 6, 2014 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Barclays Global Healthcare Conference on Wednesday, March 12, 2014, in Miami. Gary Ellis, senior vice president and chief financial officer of Medtronic, will make a presentation about Medtronic beginning at 4:15 p.m. EDT (3:15 p.m. CDT). A live audio webcast of the presentation will be available on March 12, 2014, by clicking on the Investors lin... |
|03/06/14||Medtronic Wins European Patent Office Ruling|
|MINNEAPOLIS - March 6, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that the European Patent Office (EPO) has invalidated, in its entirety, the Edwards Lifesciences EP2055266 Spenser patent which was the basis for the Aug. 26, 2013 injunction prohibiting sales of the CoreValve® System in Germany. In its ruling, the EPO in The Hague said the entire patent is invalid and therefore revoked. "Medtronic is very pleased with this ruling as it will ensure that patients across Europe who n... |
|03/03/14||Aetna and Medtronic Collaborate to Help Members Take Better Control of Type 2 Diabetes|
|- Program Aims to Improve Patients' Quality of Life and Enhance Support for Doctors to Help Create More Value in the Health Care System - HARTFORD, Conn. and MINNEAPOLIS, March 3, 2014 - Beginning this month, Aetna (NYSE: AET) and Medtronic, Inc. (NYSE: MDT) will work with doctors in a new program to reach up to 300 fully insured members with uncontrolled type 2 diabetes who may improve their health using insulin pump therapy. Eligible members will receive targeted education, case management a... |
|Receive E-mail Alerts |
|Sign up to receive e-mail alerts whenever Medtronic posts new information to the site. Just enter your e-mail address and click Submit.|